- Home
- VRAX vs RKDA Comparison
VRAX vs RKDA Comparison
Compare VRAX & RKDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- RKDA
- Stock Information
- Founded
- VRAX 2013
- RKDA 2002
- Country
- VRAX United Kingdom
- RKDA United States
- Employees
- VRAX N/A
- RKDA N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- RKDA Agricultural Chemicals
- Sector
- VRAX Health Care
- RKDA Industrials
- Exchange
- VRAX Nasdaq
- RKDA Nasdaq
- Market Cap
- VRAX 7.3M
- RKDA 6.6M
- IPO Year
- VRAX 2022
- RKDA 2015
- Fundamental
- Price
- VRAX $2.02
- RKDA $4.80
- Analyst Decision
- VRAX
- RKDA Strong Buy
- Analyst Count
- VRAX 0
- RKDA 1
- Target Price
- VRAX N/A
- RKDA $6.00
- AVG Volume (30 Days)
- VRAX 289.0K
- RKDA 10.0K
- Earning Date
- VRAX 02-05-2025
- RKDA 03-27-2025
- Dividend Yield
- VRAX N/A
- RKDA N/A
- EPS Growth
- VRAX N/A
- RKDA N/A
- EPS
- VRAX N/A
- RKDA N/A
- Revenue
- VRAX $84,872.00
- RKDA $5,482,000.00
- Revenue This Year
- VRAX $5,169.18
- RKDA N/A
- Revenue Next Year
- VRAX $66.97
- RKDA $30.00
- P/E Ratio
- VRAX N/A
- RKDA N/A
- Revenue Growth
- VRAX 7.03
- RKDA 24.00
- 52 Week Low
- VRAX $0.60
- RKDA $1.85
- 52 Week High
- VRAX $9.00
- RKDA $10.31
- Technical
- Relative Strength Index (RSI)
- VRAX 48.26
- RKDA 42.68
- Support Level
- VRAX $1.58
- RKDA $4.74
- Resistance Level
- VRAX $1.92
- RKDA $5.00
- Average True Range (ATR)
- VRAX 0.23
- RKDA 0.18
- MACD
- VRAX -0.01
- RKDA -0.03
- Stochastic Oscillator
- VRAX 43.99
- RKDA 9.43
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About RKDA Arcadia Biosciences Inc.
Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water and others.